Drugs / Bufeiyishen granule
Bufeiyishen granule
Trials 4
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 21 trial | ||||||
| Phase 2 | NCT01486186 | Dec 2011 → Dec 2014 | chronic obstructive pulmonary disease | Henan University of Traditional Chinese Medicine | Unknown | No outcome recorded |
| Phase 33 trials | ||||||
| Phase 3 | NCT03976713 | Jun 2019 → Jun 2020 | chronic obstructive pulmonary disease | Henan University of Traditional Chinese Medicine | Unknown | No outcome recorded |
| Phase 3 | NCT02270424 | Oct 2014 → Dec 2016 | chronic obstructive pulmonary disease | Henan University of Traditional Chinese Medicine | Unknown | No outcome recorded |
| Phase 3 | NCT01836016 | May 2013 → May 2015 | chronic obstructive pulmonary disease | Henan University of Traditional Chinese Medicine | Unknown | No outcome recorded |
Evidence & citations 5 cited values
Every value below carries the sentence it was read from. 6 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Bufeiyishen granule | “The experimental group will receive three type of TCM, they are Baofei granule, Bufeijianpi granule and Bufeiyishen granule.” NCT01486186 ↗ |
| Known as | Bu-fei Yi-shen granules | “We aimed to evaluate the efficacy and safety of Bu-fei Yi-shen granules (BYGs) for COPD.” PMID 37955027 ↗ Nov 2023 |
| Known as | BYGs | “We aimed to evaluate the efficacy and safety of Bu-fei Yi-shen granules (BYGs) for COPD.” PMID 37955027 ↗ Nov 2023 |
| Modality | Traditional medicine (herbal / TCM) | “patients will be given Bufei granule, Bu-Fei Jian-Pi granule, Bu-Fei Yi-Shen granule, and Yi-Qi Zi-Shen granule based on their corresponding TCM syndrome patterns, respectively.” PMID 24885672 ↗ May 2014 |
| Route | Oral | “Patients in the experimental group were prescribed BYG, while those in the control group were administered a placebo, orally, twice daily, with 5 days on and 2 days off per...” PMID 37955027 ↗ Nov 2023 |